NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 127 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $368,156 | -59.7% | 344,071 | -2.5% | 0.00% | – |
Q2 2023 | $914,399 | -36.7% | 353,050 | -0.3% | 0.00% | – |
Q1 2023 | $1,444,410 | -16.5% | 354,022 | +2.7% | 0.00% | – |
Q4 2022 | $1,730,290 | -61.0% | 344,679 | +1.7% | 0.00% | -100.0% |
Q3 2022 | $4,434,000 | +1.3% | 339,071 | -0.6% | 0.00% | 0.0% |
Q2 2022 | $4,375,000 | -2.1% | 341,251 | +16.4% | 0.00% | 0.0% |
Q1 2022 | $4,470,000 | -17.1% | 293,106 | -3.7% | 0.00% | 0.0% |
Q4 2021 | $5,394,000 | -14.3% | 304,514 | +1.7% | 0.00% | 0.0% |
Q3 2021 | $6,295,000 | +7.3% | 299,460 | +0.7% | 0.00% | 0.0% |
Q2 2021 | $5,866,000 | -26.3% | 297,440 | +8.6% | 0.00% | 0.0% |
Q1 2021 | $7,960,000 | -2.5% | 273,840 | +1.6% | 0.00% | -50.0% |
Q4 2020 | $8,164,000 | +86.1% | 269,472 | -2.3% | 0.00% | +100.0% |
Q3 2020 | $4,386,000 | -15.1% | 275,696 | +5.4% | 0.00% | 0.0% |
Q2 2020 | $5,165,000 | +58.4% | 261,639 | -1.0% | 0.00% | 0.0% |
Q1 2020 | $3,260,000 | -32.8% | 264,402 | +0.8% | 0.00% | 0.0% |
Q4 2019 | $4,849,000 | +246.1% | 262,239 | +159.1% | 0.00% | – |
Q3 2019 | $1,401,000 | +107.6% | 101,211 | +119.7% | 0.00% | – |
Q2 2019 | $675,000 | – | 46,066 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |